Ginkgo biloba supplement for rheumatoid arthritis
Part of Bones, joints & muscles, Immune system & allergy, Skin clinical trials.
This study tests whether adding a Ginkgo biloba supplement to your current rheumatoid arthritis (RA) medicines can help reduce disease activity. If you have moderate to severe RA and have been on the same disease-modifying drugs for at least six months, you may qualify.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have moderate to severe rheumatoid arthritis (based on a DAS-28 score of 3.2 or higher).
- You have been taking the same disease-modifying antirheumatic drugs (csDMARDs) for the past 6 months.
- You are not taking biologic medications for RA.
- You do not have serious liver or kidney problems, heart failure, a history of heart attack, severe anemia, active infections, other inflammatory diseases, or cancer.
- You have not had an allergic reaction to Ginkgo biloba and are not already taking it.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two additional medicines (diosmin or rebamipide) taken with standard arthritis treatment to see if they help reduce joint pain and swelling better than standard treatment alone.
This study tests whether taking omega-3 fatty acids (a type of fish oil) can help people with rheumatoid arthritis. If you join, you will receive the supplement or a placebo, and the researchers will see if it reduces your symptoms.
This trial tests whether adding L-carnitine (a natural substance) to your current treatment helps reduce rheumatoid arthritis symptoms. It could be an option if your arthritis is still active despite taking standard medications.
This trial tests whether a plant-based diet can help people with rheumatoid arthritis who have mild disease activity. You must have had RA for at least a year, be on stable medication, and not smoke or take prednisolone.
This trial tests whether a traditional Chinese herbal medicine, combined with your current rheumatoid arthritis medications, can reduce joint pain and swelling better than your current treatment alone. The study involves 6–12 months of treatment and regular check-ins with the research team.
This study tests whether adding roflumilast, a new medication, to your current rheumatoid arthritis treatment can help reduce joint inflammation and improve your symptoms. You would take it alongside methotrexate, a common RA medication you may already be using.
Hear when a new Rheumatoid Arthritis (RA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.